These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16990558)

  • 1. Critical role of inducible costimulator signaling in the development of arteriosclerosis.
    Kosuge H; Suzuki J; Haraguchi G; Koga N; Maejima Y; Inobe M; Isobe M; Uede T
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2660-5. PubMed ID: 16990558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway.
    Tanaka C; Fujimoto M; Hamaguchi Y; Sato S; Takehara K; Hasegawa M
    Arthritis Rheum; 2010 Jun; 62(6):1723-32. PubMed ID: 20191584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of the inducible costimulator molecule for the induction of allergic immune responses and its decreased expression on T helper cells after venom immunotherapy.
    Bellinghausen I; Klostermann B; Böttcher I; Knop J; Saloga J
    Immunology; 2004 May; 112(1):80-6. PubMed ID: 15096187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T helper 1/T helper 17 cells and mitigates autoimmune arthritis.
    Frey O; Meisel J; Hutloff A; Bonhagen K; Bruns L; Kroczek RA; Morawietz L; Kamradt T
    Ann Rheum Dis; 2010 Aug; 69(8):1495-501. PubMed ID: 20498202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS).
    Simpson TR; Quezada SA; Allison JP
    Curr Opin Immunol; 2010 Jun; 22(3):326-32. PubMed ID: 20116985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
    Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
    Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1.
    Taylor A; Akdis M; Joss A; Akkoç T; Wenig R; Colonna M; Daigle I; Flory E; Blaser K; Akdis CA
    J Allergy Clin Immunol; 2007 Jul; 120(1):76-83. PubMed ID: 17531298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICOS/B7RP-1 interference in mouse kidney transplantation.
    Lutz J; Lu R; Strobl M; Huang H; Deng M; Wang M; Ouyang N; Heemann U
    Transplantation; 2007 Jul; 84(2):223-30. PubMed ID: 17667814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator.
    Nakamura Y; Yasunami Y; Satoh M; Hirakawa E; Katsuta H; Ono J; Kamada M; Todo S; Nakayama T; Taniguchi M; Ikeda S
    Transplantation; 2003 Apr; 75(8):1115-8. PubMed ID: 12717187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate.
    Wang CH; Anderson N; Li SH; Szmitko PE; Cherng WJ; Fedak PW; Fazel S; Li RK; Yau TM; Weisel RD; Stanford WL; Verma S
    Circ Res; 2006 Sep; 99(6):617-25. PubMed ID: 16931795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of costimulatory pathway modulation on corneal allograft survival.
    Watson MP; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3417-22. PubMed ID: 16877411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of graft arterial disease by manipulation of the LIGHT pathway.
    Kosuge H; Suzuki J; Kakuta T; Haraguchi G; Koga N; Futamatsu H; Gotoh R; Inobe M; Isobe M; Uede T
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1409-15. PubMed ID: 15178556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial inducible costimulator ligand expression is increased during human cardiac allograft rejection and regulates endothelial cell-dependent allo-activation of CD8+ T cells in vitro.
    Klingenberg R; Autschbach F; Gleissner C; Giese T; Wambsganss N; Sommer N; Richter G; Katus HA; Dengler TJ
    Eur J Immunol; 2005 Jun; 35(6):1712-21. PubMed ID: 15864782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of inducible costimulator in the development of lupus in MRL/lpr mice.
    Tada Y; Koarada S; Tomiyoshi Y; Morito F; Mitamura M; Haruta Y; Ohta A; Nagasawa K
    Clin Immunol; 2006 Aug; 120(2):179-88. PubMed ID: 16616645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation.
    Moura R; Tjwa M; Vandervoort P; Cludts K; Hoylaerts MF
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2163-9. PubMed ID: 17761938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role for inducible costimulator in control of Salmonella enterica serovar Typhimurium infection in mice.
    Vidric M; Bladt AT; Dianzani U; Watts TH
    Infect Immun; 2006 Feb; 74(2):1050-61. PubMed ID: 16428752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of reduction rat T-lymphocytes activation and proliferation by inhibition inducible co-stimulator gene expression].
    Liu W; Bi ZG; Lu XF; Zhang ZY; Zhang SQ; Xin WG; Bo CG
    Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(4):301-4. PubMed ID: 18683771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of angio-associated migratory cell protein inhibits smooth muscle cell migration and neointima formation in accelerated atherosclerosis.
    Vogt F; Zernecke A; Beckner M; Krott N; Bosserhoff AK; Hoffmann R; Zandvoort MA; Jahnke T; Kelm M; Weber C; Blindt R
    J Am Coll Cardiol; 2008 Jul; 52(4):302-11. PubMed ID: 18634987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AILIM/ICOS-mediated elongation of activated T cells is regulated by both the PI3-kinase/Akt and Rho family cascade.
    Nukada Y; Okamoto N; Konakahara S; Tezuka K; Ohashi K; Mizuno K; Tsuji T
    Int Immunol; 2006 Dec; 18(12):1815-24. PubMed ID: 17077177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of T:B cell interactions by the inducible costimulator molecule: does ICOS "induce" disease?
    Shilling RA; Bandukwala HS; Sperling AI
    Clin Immunol; 2006 Oct; 121(1):13-8. PubMed ID: 16790364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.